Sex: U
Vaccine: COVID19, COVID19
Symptoms: Amylase, Pancreatitis
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PANCREATITIS (pancreatitis (amylase value should be around 30 to 110 highest but the patient's was verified at 6 thousand 500 and 30 as per hospital laboratory)Illness/Abdominal pain upper/Pain/Dizziness) in an elderly patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PANCREATITIS (pancreatitis (amylase value should be around 30 to 110 highest but the patient's was verified at 6 thousand 500 and 30 as per hospital laboratory)Illness/Abdominal pain upper/Pain/Dizziness) (seriousness criteria hospitalization and medically significant). The patient was hospitalized from sometime in 2021 to sometime in 2021 due to PANCREATITIS. At the time of the report, PANCREATITIS (pancreatitis (amylase value should be around 30 to 110 highest but the patient's was verified at 6 thousand 500 and 30 as per hospital laboratory)Illness/Abdominal pain upper/Pain/Dizziness) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Amylase (30-110): verified at 6 thousand 500 and 30. (abnormal) verified at 6 thousand 500 and 30. (Should be around 30 to 110 at highest). mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No concomitant medication was reported. The patient was over 70 years. Patient had received the first injection in Feb 2021 at the doctor's office. Within a short time frame, the patient became extremely ill, dizzy and had upper left quadrant severe pain radiating to back and kidney area. After reporting to the emergency room, patient was admitted with pancreatitis (amylase values were verified at 6 thousand 500 and 30) as per the hospital lab, however it should be around 30 to 110 at highest. The patient had spent at least 8 days there at that time. No treatment information was provided. Company comment: This  spontaneous case of an elderly patient above 70 years of age and unknown gender with no relevant medical history reported, who experienced the unexpected serious (medically significant/hospitalization) AESI event of Pancreatitis after receiving first dose of mRNA-1273 vaccine administration. After receiving the vaccine within a short time frame (interval unknown) patient became extremely ill, dizzy and had severe pain in left upper quadrant of abdomen radiating to back and loin. Had an emergency consultation, diagnosed as Pancreatitis and was admitted for the same. Serum amylase was increased to 6530 and was hospitalized for 8 days. Treatment details were not reported. The outcome of the event was not known at the time of report. Patient also experienced dizziness and illness after second dose which led to fall, acute traumatic brain injury. The benefit-risk relationship of mRNA-1273 (Moderna covid-19 vaccine) is not affected by this report. This case was linked to MOD-2022-512922 (Patient Link). Sender's Comments: This  spontaneous case of an elderly patient above 70 years of age and unknown gender with no relevant medical history reported, who experienced the unexpected serious (medically significant/hospitalization) AESI event of Pancreatitis after receiving first dose of mRNA-1273 vaccine administration. After receiving the vaccine within a short time frame (interval unknown) patient became extremely ill, dizzy and had severe pain in left upper quadrant of abdomen radiating to back and loin. Had an emergency consultation, diagnosed as Pancreatitis and was admitted for the same. Serum amylase was increased to 6530 and was hospitalized for 8 days. Treatment details were not reported. The outcome of the event was not known at the time of report. Patient also experienced dizziness and illness after second dose which led to fall, acute traumatic brain injury. The benefit-risk relationship of mRNA-1273 (Moderna covid-19 vaccine) is not affected by this report.